Of note, the binding of programmed cell death-1 (PD-1) by its ligand (PD-L1) triggers a co-inhibitory signaling pathway that suppresses T-cell activation, contributing to cancer immune evasion [2]. This evidence concerns the gene PDCD1 and cancer.